Published in J Acoust Soc Am on November 01, 2003
Loudness Context Effects in Normal-Hearing Listeners and Cochlear-Implant Users. J Assoc Res Otolaryngol (2015) 0.84
Induced Loudness Reduction and Enhancement in Acoustic and Electric Hearing. J Assoc Res Otolaryngol (2016) 0.78
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci (2003) 5.94
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res (2008) 4.53
NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One (2007) 3.99
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics (2004) 3.72
NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2008) 3.59
Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol (2008) 2.48
Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics (2004) 2.39
An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol (2005) 2.19
Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. Nat Immunol (2006) 2.11
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat Immunol (2009) 1.83
NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res (2010) 1.78
MHC class II epitope predictive algorithms. Immunology (2010) 1.72
CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine (2006) 1.66
NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics (2013) 1.49
HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control. J Virol (2011) 1.31
Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays. J Biomol Screen (2009) 1.27
Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells. J Virol (2010) 1.26
Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity. Eur J Immunol (2012) 1.24
HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D. J Immunol (2008) 1.24
Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology (2010) 1.21
NNAlign: a web-based prediction method allowing non-expert end-user discovery of sequence motifs in quantitative peptide data. PLoS One (2011) 1.20
HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703. J Immunol (2011) 1.18
Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. J Immunol Methods (2010) 1.18
Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: a novel strategy exploiting disulfide assisted protein folding. Protein Sci (2003) 1.16
Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol (2003) 1.12
HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides. Immunogenetics (2010) 1.11
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res (2009) 1.03
Growth of loudness in listeners with cochlear hearing losses: recruitment reconsidered. J Assoc Res Otolaryngol (2002) 1.02
Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study. Cancer Immunol Immunother (2004) 1.02
MHCcluster, a method for functional clustering of MHC molecules. Immunogenetics (2013) 1.01
HIV control through a single nucleotide on the HLA-B locus. J Virol (2012) 1.00
Discovering naturally processed antigenic determinants that confer protective T cell immunity. J Clin Invest (2013) 0.99
Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. J Gen Virol (2003) 0.98
Nef-specific CD8+ T cell responses contribute to HIV-1 immune control. PLoS One (2013) 0.98
High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide. Acta Crystallogr D Biol Crystallogr (2005) 0.95
Crystal structures of two peptide-HLA-B*1501 complexes; structural characterization of the HLA-B62 supertype. Acta Crystallogr D Biol Crystallogr (2006) 0.94
Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength. PLoS One (2011) 0.94
Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues. FEBS J (2008) 0.94
Perceptual weights in auditory level discrimination. J Acoust Soc Am (2003) 0.93
Monaural and binaural loudness of 5- and 200-ms tones in normal and impaired hearing. J Acoust Soc Am (2006) 0.93
NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery. Immunology (2014) 0.93
Genome-based in silico identification of new Mycobacterium tuberculosis antigens activating polyfunctional CD8+ T cells in human tuberculosis. J Immunol (2010) 0.93
A test of the equal-loudness-ratio hypothesis using cross-modality matching functions. J Acoust Soc Am (2005) 0.92
A strategy for bacterial production of a soluble functional human neonatal Fc receptor. J Immunol Methods (2007) 0.92
Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach. Neural Comput (2003) 0.92
Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics (2014) 0.91
A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape. Retrovirology (2015) 0.90
Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response. PLoS One (2012) 0.90
The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling. Cancer Lett (2006) 0.90
Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL. PLoS One (2010) 0.89
Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy. J Immunol (2013) 0.89
Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope. J Virol (2012) 0.89
Effect of adaptive psychophysical procedure on loudness matches. J Acoust Soc Am (2006) 0.88
Loudness enhancement: induced loudness reduction in disguise? (L). J Acoust Soc Am (2002) 0.88
Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC. Cell Immunol (2003) 0.88
Inferring basilar-membrane motion from tone-burst otoacoustic emissions and psychoacoustic measurements. J Acoust Soc Am (2005) 0.87
Loudness growth in individual listeners with hearing losses: a review. J Acoust Soc Am (2007) 0.87
Loudness of brief tones measured by magnitude estimation and loudness matching. J Acoust Soc Am (2006) 0.86
Spectral loudness summation and simple reaction time. J Acoust Soc Am (2004) 0.86
Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions. BMC Bioinformatics (2014) 0.85
Wildtype p53-specific antibody and T-cell responses in cancer patients. J Immunother (2011) 0.85
HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01. J Virol (2013) 0.85
Changes in protein expression in p53 deleted spontaneous thymic lymphomas. Exp Cell Res (2004) 0.85
Soluble human leukocyte antigen-G in seminal plasma is associated with HLA-G genotype: possible implications for fertility success. Am J Reprod Immunol (2014) 0.85
HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses. PLoS One (2010) 0.85
The outermost N-terminal region of tapasin facilitates folding of major histocompatibility complex class I. Eur J Immunol (2009) 0.85
A test of the binaural equal-loudness-ratio hypothesis for tones. J Acoust Soc Am (2006) 0.83
A comparison of psychophysical procedures for level-discrimination thresholds. J Acoust Soc Am (2003) 0.83
Oriented coupling of major histocompatibility complex (MHC) to sensor surfaces using light assisted immobilisation technology. Biosens Bioelectron (2005) 0.83
Clinical application of dendritic cells in cancer vaccination therapy. APMIS (2003) 0.83
Tapasin facilitation of natural HLA-A and -B allomorphs is strongly influenced by peptide length, depends on stability, and separates closely related allomorphs. J Immunol (2013) 0.83
MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides. PLoS One (2013) 0.83
Binaural loudness summation for speech and tones presented via earphones and loudspeakers. Ear Hear (2009) 0.82
Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides. Immunology (2011) 0.82
Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.81
Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display. Sci Rep (2013) 0.81
Identification of a new hTERT-derived HLA-A*0201 restricted, naturally processed CTL epitope. Cancer Immunol Immunother (2007) 0.81
A novel system for continuous protein refolding and on-line capture by expanded bed adsorption. Protein Sci (2005) 0.81
Use of "one-pot, mix-and-read" peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle. Vet Res (2014) 0.80
The effects of window delay, delinearization, and frequency on tone-burst otoacoustic emission input/output measurements. J Acoust Soc Am (2004) 0.80
Identification of conserved subdominant HIV Type 1 CD8(+) T Cell epitopes restricted within common HLA Supertypes for therapeutic HIV Type 1 vaccines. AIDS Res Hum Retroviruses (2012) 0.80
HIV subtype influences HLA-B*07:02-associated HIV disease outcome. AIDS Res Hum Retroviruses (2013) 0.80
Reaction time to 1- and 4-kHz tones as a function of sensation level in listeners with normal hearing. Ear Hear (2006) 0.80
Incomplete effector/memory differentiation of antigen-primed CD8+ T cells in gene gun DNA-vaccinated mice. Eur J Immunol (2003) 0.80
Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes. PLoS One (2010) 0.80
Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery. Immunogenetics (2014) 0.79
Comparison of CTL reactivity in the spleen and draining lymph nodes after immunization with peptides pulsed on dendritic cells or mixed with Freund's incomplete adjuvant. Immunol Lett (2003) 0.79
Auditory frequency focusing is very rapid. J Acoust Soc Am (2010) 0.79
HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes. Diabetes (2012) 0.79
Testing the binaural equal-loudness-ratio hypothesis with hearing-impaired listeners. J Acoust Soc Am (2009) 0.79
Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load. AIDS (2014) 0.79
Carbon anhydrase IX specific immune responses in patients with metastatic renal cell carcinoma potentially cured by interleukin-2 based immunotherapy. Immunopharmacol Immunotoxicol (2013) 0.78
Identification of an HLA-A*0201 restricted Bcl2-derived epitope expressed on tumors. Cancer Lett (2006) 0.78
Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53. Proteome Sci (2008) 0.78